Trials / Completed
CompletedNCT00292461
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 16 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of zonisamide for anti-epilepsy drugs (AEDs) treated subjects with refractory simple partial, complex partial or partial with secondary generalized seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zonisamide | Tablet once or twice daily orally for 16 weeks |
| DRUG | Lamotrigine | Tablet once daily orally for 16 weeks |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2009-08-01
- Completion
- 2009-09-01
- First posted
- 2006-02-16
- Last updated
- 2013-05-20
- Results posted
- 2011-08-15
Locations
8 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00292461. Inclusion in this directory is not an endorsement.